Adenosine triphosphate affects interleukin -1beta release by T98G glioblastoma cells through a purinoceptor-independent mechanism

Neurosci Lett. 2000 May 19;285(3):218-22. doi: 10.1016/s0304-3940(00)01051-x.

Abstract

T98G glioblastoma cells were previously shown to significantly increase interleukin-1beta (IL-1beta) mRNA levels in response to IL-1beta stimulation. This work demonstrates that in such conditions T98G, despite possessing biologically active interleukin converting enzyme, do not release detectable amounts of IL-1beta, even in the presence of 20 mM adenosine triphosphate (ATP). IL-1beta secretion is observed only following concomitant stimulation with 1000 units/ml of IL-1beta and 20 mM ATP. ATP induces a dose-dependent depolarization of T98G plasma membrane, whereas it does not affect Ca(2+) concentration or cell membrane permeability. Our data, together with the observation that the depolarizing effects of ATP are retained after preincubation with 100 microM suramin, an antagonist of P2-purinoceptors, suggest that ATP plays a role in IL-1beta secretion by T98G but its effects do not occur through P2-purinoceptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Antineoplastic Agents / pharmacology
  • Cell Membrane / drug effects*
  • Cell Membrane / physiology
  • Dose-Response Relationship, Drug
  • Glioblastoma / metabolism
  • Interleukin-1 / metabolism*
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Purinergic P2 Receptor Antagonists*
  • Receptors, Purinergic P2 / physiology
  • Suramin / pharmacology
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism

Substances

  • Antineoplastic Agents
  • Interleukin-1
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2
  • Suramin
  • Adenosine Triphosphate